Gemcitabine lipid prodrug nanoparticles: Switching the lipid moiety and changing the fate in the bloodstream.
Coppens E, Desmaële D, Naret T, Garcia-Argote S, Feuillastre S, Pieters G, Cailleau C, Paul JL, Prost B, Solgadi A, Michel JP, Noiray M, Couvreur P, Mura S.
Coppens E, et al. Among authors: cailleau c.
Int J Pharm. 2021 Nov 20;609:121076. doi: 10.1016/j.ijpharm.2021.121076. Epub 2021 Sep 2.
Int J Pharm. 2021.
PMID: 34481886
Free article.